Deepithelialized skin diffusion cell system

Details Deepithelialized skin diffusion cell system Deepithelialized skin diffusion cell system

1997-06-19

1999-03-02

Krass, Frederick

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

436 63, 436 87, 436164, 436166, 436175, 436804, 436805, 436807, 436825, G01N 2100, G01N 2175

Patent

active

058771492

ABSTRACT:
A deepithelialized skin cell diffusion system which can be used to select topical gel and cream formulations containing human other wound healing promoters such as plasma fibronectin. The formulations provide slow release and increased contact time of fibronectin or other wound healing promoters to the wound site leading to its effective absorption.

REFERENCES:
patent: 4594884 (1986-06-01), Bondi et al.
patent: 5457093 (1995-10-01), Cini et al.

Affiliated with

Also associated with

Rating

Deepithelialized skin diffusion cell system does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Deepithelialized skin diffusion cell system, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Deepithelialized skin diffusion cell system will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-422922